Pharma firm Anges and Osaka University to begin testing coronavirus vaccine on animals
[TOKYO] Japanese biopharmaceutical firm Anges Inc said on Tuesday it and partner Osaka University had completed development of a prophylactic DNA vaccine against the new coronavirus and that it would begin testing it in animals soon.
Shares of Anges were untraded with a glut of buy orders in early morning.
There are now more than 350,000 cases of coronavirus infections globally and over 15,000 deaths resulting from the disease it causes, called Covid-19.
REUTERS
GET BT IN YOUR INBOX DAILY
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Gazelle Ventures makes cash offer for No Signboard shares at S$0.0021 apiece
Marina Bay Sands Q1 profit surges 51.5% to US$597 million on tourism boom
Swiss watch exports plunge as China and Hong Kong demand dries up
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Billionaires selling cheap stuff get richer from inflation pain
Amazon to push cashierless shopping tech into more third-party stores, while backing off itself